PackGene Biotech

PackGene is a world-leading adeno-associated virus (AAV) vector CRO and CDMO company. We specialize in providing cost-effective and scalable plasmid DNA and AAV viral vector production for Cell and Gene Therapy (CGT). Our services cater to early-stage drug discovery, preclinical development, and clinical trials.

Utilizing our proprietary π-Alpha™ 293 AAV High-yield Platform, we employ a triple-plasmid transfection system to significantly increase AAV production by up to 8 fold. Through in-process upstream and downstream QbD optimizations, we can further boost total AAV yield up to 10 fold. With a single batch, we can deliver up to 1E+17vg virus particles, meeting the requirements of most commercial and clinical projects.

Our offerings also include GMP grade gene therapeutics, rAAV packaging, and vector cloning. We have garnered recognition and support globally, becoming a trusted partner in the field of viral vector manufacturing. At PackGene, our mission is to Make Gene Therapy Affordable.

We focus on rAAV serotype selection, viral vector packaging, and GMP production scale-up, providing stable, qualified, and cost-efficient fast services and technical support. Contact us today to see how we can help in advancing your gene therapy endeavors